NCT00303017

Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study

Safety, Efficacy and Acceptability of Flavocoxid (Limbrel) Compared With Naproxen in Subjects With Osteoarthritis of the Knee. A Pilot Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Primus Pharmaceuticals · Industry
• Sex: All
• Age: 30 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

safety, efficacy and acceptability of Flavocoxid

Detailed description

Safety, Efficacy and acceptability of Flavocoxid (Limbrel) compared with Naproxen in Subjects with Osteoarthritis of the Knee. A Pilot Study

Conditions

• Osteoarthritis

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	flavocoxid	flavonoid mixture
DRUG	Naproxen	non-steroidal anti-inflammatory drug

Timeline

• Start date: 2006-03-01
• Primary completion: 2006-07-01
• Completion: 2006-09-01
• First posted: 2006-03-15
• Last updated: 2015-10-21

Locations

1 site across 1 country: United States